RxDoctor Payments Data

Grant Belnap, MD

Addiction Psychiatry · St George, UTNPI 1356481790

Payments from drug & device makers

$1,462in general payments, 2019–2025

Across 90 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$421
  • AbbVie$237
  • Sunovion Pharmaceuticals Inc.$198
  • Takeda Pharmaceuticals U.S.A., Inc.$173
  • Johnson & Johnson$115
  • Tris Pharma Inc$60
  • plus $258 from 10 others

What the payments were for

  • Food & beverage$1,456100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few addiction psychiatry providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$25,037
Medicare patients
61
Services billed
242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide24$20,805
Aripiprazole78$9,115
Desvenlafaxine Succinate ErDesvenlafaxine Succinate69$6,904
Olanzapine62$5,481
Dextroamphetamine Sulfate12$4,041
Divalproex Sodium36$3,985
Venlafaxine Hcl ErVenlafaxine Hcl184$3,450
Bupropion XlBupropion Hcl168$3,299
Fluphenazine Hcl17$2,984
Duloxetine Hcl112$2,944
Ziprasidone Hcl15$2,511
Clonazepam250$1,997
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine49$1,926
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$1,873
Lamotrigine147$1,870

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$173$20,80524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few addiction psychiatry providers in Utahon file to place this against a meaningful peer group, so we don't.

Other addiction psychiatry in St George

Where these figures come from

Is this you, or does something look wrong? →